Managing Partner

(212) 739-7876

Linkedin

Adam has a unique background with a wealth of experience as both a senior Healthcare executive and a Wall Street veteran. He has over 20 years of experience working with many of the leading Healthcare Services companies. He is the Chairman of the Board at HealthChannels (ScribeAmerica), the nation’s leading provider of medical scribes and solutions. He also currently serves on the Board of Directors at PathGroup, a leading pathology services company, Imedex, the leading provider of accredited continuing medical education (CME) for oncologists, Surgery Partners (NASDAQ: SGRY), a leading surgery center and physician services organization and Quorum Healthcare Corporation (NYSE: QHC), a rural hospital operator.

Prior to founding VSCP, he was the Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at Laboratory Corporation of America Holdings (LabCorp) where he oversaw M&A, Corporate Development, Strategic Partnerships and Corporate Strategy and managed the company’s partnerships with large Hospital Systems. He also created the LabCorp private equity investment vehicle.

Prior to LabCorp, Adam was the Managing Director in Equity Research at Barclays Capital/Lehman Brothers for 14 years, where he covered, as well as coordinated, the firm's Health Care Facilities and Services research teams. He was ranked #1 in the Institutional Investor All America Research Survey in the Health Care Facilities category, for a decade and was considered the best Healthcare Services analyst on Wall Street. He covered many of the top Healthcare organizations and completed capital market transactions for companies, including HCA, Team Health, Psychiatric Solutions, Universal Health Services, Tenet Healthcare, United Surgical Partners, AmSurg and Vanguard Health Services.

Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland at College Park. He also completed the Nashville Healthcare Council Fellows program.

General Partner

(212) 739-7876

Linkedin

Larry joined the Vesey Street team, bringing his long background and experience both as a senior Healthcare executive and a Wall Street veteran. Larry has been in the Healthcare industry for close to 30 years and created the Healthcare Services team at Lehman Brothers with Mr Feinstein close to 20 years ago. He is currently a member of the Board of Directors at HealthChannels and Imedex. Prior to his joining VSCP, he was Executive Vice President of New Market Development and Chief Strategy Officer at AmerisourceBergen, a Fortune 15 pharmaceutical and Healthcare services organization. While there, the company completed over 30 M&A transactions that represented in excess of $7 billion in capital.

Prior to AmerisourceBergen, Larry was the Managing Director in Equity Research at Barclays Capital/Lehman Brothers, where he covered and coordinated the Healthcare Distribution & Technology segment. He was ranked #1 in the Institutional Investor All America Research Survey in that category for nine years and was considered a leading voice on Wall Street. He received his Master of Public Health degree from Columbia University, as well as his MBA and BS from the University of Richmond.

General Partner

(212) 739-7876

Linkedin

Dan joined Vesey Street Capital Partners in 2014 and serves as a General Partner for the firm.  In addition to sourcing and evaluating potential investment opportunities, Dan with works closely with VSCP's portfolio companies and is a Board Member of Imedex as well as a Board Observer of HealthChannels.

Prior to joining Vesey Street, Dan worked with Adam, Larry, and Joe at Barclays Capital as a Vice President and Research Analyst focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Dan has worked with the Vesey Street team since joining the group at Lehman Brothers in 2007.

Dan received a B.S. in Management Science from the University of California – San Diego and is a CFA charterholder.

Joe joined Vesey Street Capital Partners in 2014 and is a General Partner for the firm.  Joe is intimately involved with each portfolio company and is responsible for evaluating new investment opportunities.  Additionally, Joe serves as a Board Observer for HealthChannels and Imedex.

Prior to joining Vesey Street, Joe was a Research Analyst at S.A.C. Capital, where he was responsible for Healthcare Services investments across a $500 million Healthcare-dedicated portfolio.  His sector mandate encompassed over 100 Healthcare Services companies, ranging from Hospitals and Post-Acute care to Healthcare Technology and Digital Health.  Prior to his time at S.A.C., Joe worked with Adam, Larry and Dan at Barclays Capital, focusing on the Managed Care sector.  Overall, Joe has over eight years of experience covering the Healthcare Services sector.

Joe received a B.A. in History from Georgetown University where he was a member of the Division I-AA football team, and an M.B.A. from Columbia Business School.

David joined Vesey Street Capital Partners in 2016 as a General Partner from Morgan Stanley, where he was a Managing Director and head of US institutional equity sales in New York and other regions and several other businesses within US equities. Morgan Stanley's equity sales effort was consistently top-ranked in industry polls during his tenure. He worked closely with other members of the VSCP team over many years at Lehman Brothers, where he was a Managing Director in US institutional equity sales and received the firm's Chairman Award three times. David was a corporate litigation associate at Simpson Thacher & Bartlett and senior aide to United States Senator Daniel Patrick Moynihan in Washington.

David is Vice Chairman of the Board of Trustees of the Winterthur Museum (Wilmington, DE), the nation's largest museum for American decorative arts, and chairs the Investment Committee. He is also a trustee of Weantinoge Heritage Land Trust, Connecticut's largest land trust. He holds a BA from Brown University, where he was elected to Phi Beta Kappa, an MSc from the London School of Economics, and a JD from Columbia Law School. David received the Saint David's School Alumnus of the Year Award in 2012.

Chief Financial Officer

(212) 739-7876

Linkedin

Bryan joined Vesey Street Capital Partners in 2016 and is the Chief Financial Officer of the firm.  Prior to joining VSCP, Bryan Sekino worked at Brant Point Capital Management, where he was responsible for healthcare investments across a diversified portfolio.  He was also an analyst at Lehman Brothers and Barclays Capital working with Adam, Larry, Dan and Joe and focusing on the Healthcare Facilities sector.  Overall, Bryan has over nine years of experience covering the Healthcare Services sector.  Prior to his time as a research analyst, Bryan also spent four years working in operations at Lehman Brothers.

Bryan is a CFA charterholder and received a B.A. from The University of Michigan and an M.B.A. from Columbia Business School.